NO994622D0 - Anvendelse av proteiner som kan ekstraheres fra animalske organer for fremstilling av medikamenter for behandling av patologiske tilstander som er saerpreget ved hyperproduksjon av tumornekrosefaktor (TNF) - Google Patents

Anvendelse av proteiner som kan ekstraheres fra animalske organer for fremstilling av medikamenter for behandling av patologiske tilstander som er saerpreget ved hyperproduksjon av tumornekrosefaktor (TNF)

Info

Publication number
NO994622D0
NO994622D0 NO994622A NO994622A NO994622D0 NO 994622 D0 NO994622 D0 NO 994622D0 NO 994622 A NO994622 A NO 994622A NO 994622 A NO994622 A NO 994622A NO 994622 D0 NO994622 D0 NO 994622D0
Authority
NO
Norway
Prior art keywords
tumor
tnf
distinctive
drugs
proteins
Prior art date
Application number
NO994622A
Other languages
English (en)
Norwegian (no)
Other versions
NO994622L (no
Inventor
Alberto E Panerai
Pier Luigi Meroni
Alberto Bartorelli
Original Assignee
Zetesis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zetesis Spa filed Critical Zetesis Spa
Publication of NO994622D0 publication Critical patent/NO994622D0/no
Publication of NO994622L publication Critical patent/NO994622L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO994622A 1997-03-25 1999-09-23 Anvendelse av proteiner som kan ekstraheres fra animalske organer for fremstilling av medikamenter for behandling av patologiske tilstander som er saerpreget ved hyperproduksjon av tumornekrosefaktor (TNF) NO994622L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI000694A IT1290828B1 (it) 1997-03-25 1997-03-25 Uso di proteine estraibili da organi animali per la preparazione di medicamenti per il trattamento di condizioni patologiche
PCT/EP1998/001516 WO1998042366A1 (en) 1997-03-25 1998-03-16 The use of proteins extractable from animal organs for the preparation of medicaments for the treatment of pathological conditions characterized by hyperproduction of tumor necrosis factor (tnf)

Publications (2)

Publication Number Publication Date
NO994622D0 true NO994622D0 (no) 1999-09-23
NO994622L NO994622L (no) 1999-09-23

Family

ID=11376611

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994622A NO994622L (no) 1997-03-25 1999-09-23 Anvendelse av proteiner som kan ekstraheres fra animalske organer for fremstilling av medikamenter for behandling av patologiske tilstander som er saerpreget ved hyperproduksjon av tumornekrosefaktor (TNF)

Country Status (16)

Country Link
US (1) US6255283B1 (it)
EP (1) EP0969859A1 (it)
JP (1) JP2001518107A (it)
KR (1) KR20010005705A (it)
CN (1) CN1251043A (it)
AU (1) AU7207298A (it)
BR (1) BR9808625A (it)
CA (1) CA2284548A1 (it)
HU (1) HUP0002304A3 (it)
IL (1) IL132013A0 (it)
IT (1) IT1290828B1 (it)
NO (1) NO994622L (it)
NZ (1) NZ337985A (it)
PL (1) PL335829A1 (it)
TR (1) TR199902331T2 (it)
WO (1) WO1998042366A1 (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030153511A1 (en) * 2000-06-08 2003-08-14 Alberto Panerai Method of treatment of huntington's chorea with a protein extractable from mammalian organs
US20030165492A1 (en) * 2000-06-08 2003-09-04 Alberto Panerai Method of treatment of alzheimer's disease with a protein extractable from mammalian organs
WO2001093888A2 (en) * 2000-06-08 2001-12-13 Rakepoll Holding B.V. A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs
CA2411430A1 (en) * 2000-06-08 2001-12-13 Rakepoll Holding B.V. A method of treatment of parkinson's disease with a protein extractable from mammalian organs
ITMI20010762A1 (it) * 2001-04-10 2002-10-10 Zetesis Spa Uso della proteina uk114 o di suoi frammenti per il trattamento e la prevenzione dello shock endotossico
ITMI20021205A1 (it) * 2002-06-04 2003-12-04 Pharmaproducts Uk Ltd Uso di proteine per il trattamento della leishmaniosi
IT201600127428A1 (it) * 2016-12-16 2018-06-16 Cusani Alberto Bartorelli Nuova proteina ricombinante uk 114 in forma stabile polimerica per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2251186A (en) * 1990-12-04 1992-07-01 Randall Neal Gatz Polypeptide for use in treatment of autoimmune disease
FR2688227A1 (fr) * 1992-03-04 1993-09-10 Inst Nat Sante Rech Med Proteines formant des complexes avec des chaperones et leurs ligands, leurs fragments, leur obtention et leurs applications biologiques.
US5997873A (en) * 1994-01-13 1999-12-07 Mount Sinai School Of Medicine Of The City University Of New York Method of preparation of heat shock protein 70-peptide complexes
IT1270618B (it) * 1994-07-14 1997-05-07 Zetesis Spa Proteine ad attivita' antitumorale
GB9419553D0 (en) 1994-09-27 1994-11-16 Univ Bristol Polypeptides and their use in the treatment of auto-immune disease
CN1151838C (zh) 1996-09-18 2004-06-02 泽特希斯有限公司 作为抗自身免疫疾病试剂的蛋白的用途
US6007821A (en) * 1997-10-16 1999-12-28 Fordham University Method and compositions for the treatment of autoimmune disease using heat shock proteins

Also Published As

Publication number Publication date
KR20010005705A (ko) 2001-01-15
US6255283B1 (en) 2001-07-03
WO1998042366A1 (en) 1998-10-01
AU7207298A (en) 1998-10-20
TR199902331T2 (xx) 2000-01-21
HUP0002304A2 (hu) 2000-11-28
IT1290828B1 (it) 1998-12-11
ITMI970694A1 (it) 1998-09-25
PL335829A1 (en) 2000-05-22
CN1251043A (zh) 2000-04-19
JP2001518107A (ja) 2001-10-09
HUP0002304A3 (en) 2001-12-28
IL132013A0 (en) 2001-03-19
EP0969859A1 (en) 2000-01-12
NZ337985A (en) 2001-02-23
BR9808625A (pt) 2000-05-16
CA2284548A1 (en) 1998-10-01
NO994622L (no) 1999-09-23

Similar Documents

Publication Publication Date Title
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60303238D1 (de) Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten
ATE430569T1 (de) Neue arzneimittel zur behandlung von chronisch obstruktiver lungenerkrankung
ATE417606T1 (de) Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege
BR9710372A (pt) Composto composi-Æo farmac-utica e processos para o tratamento de uma doen-a inflamatÄria e de doen-as mediadas pela cliclooxigenase
ATE259812T1 (de) Neue substituierte pyrazolderivate zur behandlung von herzkreislauferkrankungen
NO20005864D0 (no) Quinasoler til behandling av hjernesvulst
DE602004020072D1 (de) 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen
DE60031710D1 (de) Fettsäurederivat zur behandlung von externen sekretionsstörungen
DE60033040D1 (de) Emulsionsverfahren zur herstellung von mikropartikeln
ATE292134T1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE60030554T8 (de) Verwendungen von et743 zur behandlung von krebs
NO994622L (no) Anvendelse av proteiner som kan ekstraheres fra animalske organer for fremstilling av medikamenter for behandling av patologiske tilstander som er saerpreget ved hyperproduksjon av tumornekrosefaktor (TNF)
ITMI962745A0 (it) Sonda-catetere per il trattamento di tumori di organi parenchimatosi con ipertermia interstiziale indotta da radiofrequenza
NO20033622L (no) Fremgangsmate for behandling av demyeliniserende sykdommer eller tilstander
WO2002064741A3 (en) Compositions and methods relating to breast specific genes and proteins
WO2002040673A3 (en) Compositions and methods relating to lung specific genes and proteins
DE60120990D1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
DE60229044D1 (de) Magensaftresistente salze von ketosäuren und aminosäuren und ihre verwendung zur herstellung von medikamenten
ATE353693T1 (de) Neue piperazinyl-pyrazinon-derivate zur behandlung von 5-ht2a rezeptor-bedingten erkrankungen
DE60017174D1 (de) Rivastigmine zur behandlung von augenerkrankungen
DE60005685D1 (de) Oxazinocarbazole zur behandlung von cns-erkrankungen
DE69935156D1 (de) hCG THERAPIE ZUR BEHANDLUNG VON METASTATISCHEM BRUSTKREBS
WO2003066877A3 (en) Compositions and methods relating to hepatic specific genes and proteins

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application